These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33926762)

  • 1. Impact of Metabolic Syndrome in the Clinical Outcome of Disease by SARS-COV-2.
    León-Pedroza JI; Rodríguez-Cortés O; Flores-Mejía R; Gaona-Aguas CV; González-Chávez A
    Arch Med Res; 2021 Oct; 52(7):738-745. PubMed ID: 33926762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence and contributing risk factors of coronavirus disease 2019 infection in patients with metabolic syndrome.
    Bagheri-Hosseinabadi Z; Moadab F; Amiri A; Abbasifard M
    BMC Endocr Disord; 2023 May; 23(1):100. PubMed ID: 37142990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome and the risk of COVID-19 infection: A nationwide population-based case-control study.
    Cho DH; Choi J; Gwon JG
    Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2596-2604. PubMed ID: 34348879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Number of Metabolic Syndrome Components Is the Central Predictor of the Impact of Metabolic Syndrome on Outcome of Percutaneous Nephrolithotomy in Staghorn Nephrolithiasis.
    Xu P; Wang J
    J Endourol; 2019 Nov; 33(11):946-953. PubMed ID: 31333070
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of Metabolic Syndrome on Severity of COVID-19 Illness.
    Wu S; Zhou K; Misra-Hebert A; Bena J; Kashyap SR
    Metab Syndr Relat Disord; 2022 May; 20(4):191-198. PubMed ID: 34995147
    [No Abstract]   [Full Text] [Related]  

  • 6. Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study.
    Abayomi A; Osibogun A; Kanma-Okafor O; Idris J; Bowale A; Wright O; Adebayo B; Balogun M; Ogboye S; Adeseun R; Abdus-Salam I; Mutiu B; Saka B; Lajide D; Yenyi S; Agbolagorite R; Onasanya O; Erinosho E; Obasanya J; Adejumo O; Adesola S; Oshodi Y; Akase IE; Ogunbiyi S; Omosun A; Erinoso F; Abdur-Razzaq H; Osa N; Akinroye K
    Glob Health Res Policy; 2021 Jul; 6(1):26. PubMed ID: 34325747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-Cause and Cardiovascular Mortality Among Koreans: Effects of Obesity and Metabolic Health.
    Sung KC; Ryu S; Cheong ES; Kim BS; Kim BJ; Kim YB; Chung PW; Wild SH; Byrne CD
    Am J Prev Med; 2015 Jul; 49(1):62-71. PubMed ID: 26094228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
    Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
    Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19.
    Denson JL; Gillet AS; Zu Y; Brown M; Pham T; Yoshida Y; Mauvais-Jarvis F; Douglas IS; Moore M; Tea K; Wetherbie A; Stevens R; Lefante J; Shaffer JG; Armaignac DL; Belden KA; Kaufman M; Heavner SF; Danesh VC; Cheruku SR; St Hill CA; Boman K; Deo N; Bansal V; Kumar VK; Walkey AJ; Kashyap R;
    JAMA Netw Open; 2021 Dec; 4(12):e2140568. PubMed ID: 34935924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome and risk of COVID-19-related hospitalization: a large, population-based cohort study carried out during the first European outbreak of SARS-CoV-2 infection in the Metropolitan area of Milan (Lombardy Region, Northern Italy).
    Gervasi F; Andreano A; Russo AG
    Epidemiol Prev; 2021; 45(6):477-485. PubMed ID: 34791868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
    Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
    Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.
    Park BE; Lee JH; Park HK; Kim HN; Jang SY; Bae MH; Yang DH; Park HS; Cho Y; Lee BY; Nam CW; Lee JB; Kim U; Chae SC;
    J Korean Med Sci; 2021 Jan; 36(2):e15. PubMed ID: 33429474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Impact of Preexisting Comorbidities on Overall Clinical Outcomes of Hospitalized COVID-19 Patients.
    Koyyada R; Nagalla B; Tummala A; Singh AD; Patnam S; Barigala R; Kandala M; Krishna V; Manda SV
    Biomed Res Int; 2022; 2022():2349890. PubMed ID: 35402606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evolution of patients infected with SARS-CoV-2 according to previous metabolic status].
    Martínez Urbistondo M; Mora Vargas A; Expósito Palomo E; Aparicio de Miguel M; Castejón Díaz R; Daimiel L; Ramos López O; San Cristóbal R; Martínez JA; Vargas Núñez JA
    Nutr Hosp; 2021 Oct; 38(5):1068-1074. PubMed ID: 34176273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension, Diabetes and Obesity, Major Risk Factors for Death in Patients with COVID-19 in Mexico.
    Peña JE; Rascón-Pacheco RA; Ascencio-Montiel IJ; González-Figueroa E; Fernández-Gárate JE; Medina-Gómez OS; Borja-Bustamante P; Santillán-Oropeza JA; Borja-Aburto VH
    Arch Med Res; 2021 May; 52(4):443-449. PubMed ID: 33380361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19.
    Shah H; Khan MSH; Dhurandhar NV; Hegde V
    Acta Diabetol; 2021 Jul; 58(7):831-843. PubMed ID: 33587177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Syndemic Pandemic in Portugal: Social Inequality in Risk Factors Associated With COVID-19 Mortality].
    Perelman J
    Acta Med Port; 2022 Jun; 35(6):433-449. PubMed ID: 35533082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of metabolic syndrome and COVID-19 deterioration.
    Ouedraogo E; Allard L; Bihan H; Goupil de Bouillé J; Giroux-Leprieur B; Sutton A; Baudry C; Josse C; Didier M; Deutsch D; Rezgani I; Bouchaud O; Cosson E
    Nutr Metab Cardiovasc Dis; 2021 Oct; 31(11):3236-3242. PubMed ID: 34629251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and impact of diabetes and cardiovascular disease on clinical outcome among patients with COVID-19 in Bangladesh.
    Sharif N; Ahmed SN; Opu RR; Tani MR; Dewan D; Daullah MU; Shanto RI; Parvez AK; Talukder AA; Dey SK
    Diabetes Metab Syndr; 2021; 15(3):1009-1016. PubMed ID: 33993046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.